DPI-221
Systematic (IUPAC) name | |
---|---|
4-((αS)-α-((2S,5R)-2,5-dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide | |
Identifiers | |
PubChem | CID 9891642 |
Chemical data | |
Formula | C21H38FN3O |
Molar mass | 487.65 g/mol |
| |
(verify) |
DPI-221 is a opioid drug that is used in scientific research. It is a highly selective agonist for the δ-opioid receptor, which produces fewer convulsions than most drugs from this family.[1]
References
- ↑ Holt, JD; Watson, MJ; Chang, JP; O'Neill, SJ; Wei, K; Pendergast, W; Gengo, PJ; Chang, KJ (2005). "DPI-221 4-((alpha-s)-alpha-((2s,5r)-2,5-dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide: a novel nonpeptide delta receptor agonist producing increased micturition interval in normal rats". The Journal of Pharmacology and Experimental Therapeutics 315 (2): 601–8. doi:10.1124/jpet.105.090498. PMID 16020629.
This article is issued from Wikipedia - version of the Friday, July 25, 2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.